World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
29702
World Ranking
10549
National Ranking
5429

Dennis S. Chi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dennis S. Chi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 629 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dennis S. Chi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dennis S. Chi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Surgery
  • Cancer
  • Internal medicine

His primary areas of study are Surgery, Ovarian cancer, Stage, Hysterectomy and Internal medicine. His Surgery research incorporates elements of Stage IIIC, Cervical cancer and Disease. His study of Debulking is a part of Ovarian cancer.

His Stage study incorporates themes from Gynecologic oncology, Urology, Carcinoma, Radiology and Gynecology. Dennis S. Chi combines subjects such as Endometrial cancer and Adjuvant therapy with his study of Hysterectomy. His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology.

His most cited work include:

  • Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer (479 citations)
  • What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC) (463 citations)
  • Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm (391 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Surgery, Ovarian cancer, Internal medicine, Oncology and Debulking. Many of his research projects under Surgery are closely connected to In patient with In patient, tying the diverse disciplines of science together. He works mostly in the field of Ovarian cancer, limiting it down to topics relating to Chemotherapy and, in certain cases, Serous fluid, as a part of the same area of interest.

Dennis S. Chi regularly ties together related areas like Gastroenterology in his Internal medicine studies. His Debulking research is multidisciplinary, incorporating perspectives in Ovarian carcinoma, Perioperative, Radiology, Stage IIIC and Cohort. Dennis S. Chi interconnects Hysterectomy and Gynecology in the investigation of issues within Endometrial cancer.

He most often published in these fields:

  • Surgery (66.18%)
  • Ovarian cancer (42.48%)
  • Internal medicine (35.95%)

What were the highlights of his more recent work (between 2018-2021)?

  • Surgery (66.18%)
  • Ovarian cancer (42.48%)
  • Debulking (26.14%)

In recent papers he was focusing on the following fields of study:

Dennis S. Chi mostly deals with Surgery, Ovarian cancer, Debulking, Internal medicine and Chemotherapy. His Surgery research includes themes of Adverse effect and Cohort. His Ovarian cancer study combines topics from a wide range of disciplines, such as Resection, Disease and Diaphragmatic hernia, Hernia.

His Debulking research integrates issues from Complication, Retrospective cohort study, Cardiothoracic surgery and Ovary. His study ties his expertise on Oncology together with the subject of Internal medicine. The Chemotherapy study combines topics in areas such as Ovarian carcinoma, Serous fluid, Univariate analysis, Surgical oncology and Triage.

Between 2018 and 2021, his most popular works were:

  • TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7) (34 citations)
  • Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy (22 citations)
  • Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes (16 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Surgery
  • Internal medicine

Dennis S. Chi mainly investigates Ovarian cancer, Surgery, Debulking, Chemotherapy and Internal medicine. His work deals with themes such as Algorithm, Disease, Triage and Hazard ratio, which intersect with Ovarian cancer. His Surgery research is multidisciplinary, relying on both Polypharmacy and Cohort.

The study incorporates disciplines such as Complication, Intensive care unit, Depression and Geriatrics in addition to Debulking. His Chemotherapy research includes elements of Cancer, Framingham Risk Score, Ovarian carcinoma, Contraindication and Retrospective cohort study. His work carried out in the field of Internal medicine brings together such families of science as Oncology and Robotic surgery.

Best Publications

  • What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)

    D. S. Chi;E. L. Eisenhauer;J. Lang;J. Huh

  • Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

    Dennis S. Chi;Eric L. Eisenhauer;Oliver Zivanovic;Yukio Sonoda

  • Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer

    Jeff Boyd;Yukio Sonoda;Mark G. Federici;Faina Bogomolniy

  • Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis

    Robert E. Bristow;Dennis S. Chi

  • The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: Beyond removal of blue nodes

    Joyce N. Barlin;Fady Khoury-Collado;Christine H. Kim;Mario M. Leitao

  • Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis

    Robert E. Bristow;Isha Puri;Dennis S. Chi

  • The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center.

    Nadeem R. Abu-Rustum;Kaled Alektiar;Alexia Iasonos;Gali Lev

  • Peritoneal Metastases: Detection with Spiral CT in Patients with Ovarian Cancer

    Fergus V. Coakley;Patricia H. Choi;Christina A. Gougoutas;Bhavana Pothuri

  • Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.

    Dennis S. Chi;Kristina McCaughty;John P. Diaz;Jae Huh

  • The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.

    Eric L. Eisenhauer;Nadeem R. Abu-Rustum;Yukio Sonoda;Douglas A. Levine

  • Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

    Dennis S. Chi;Corinna C. Franklin;Douglas A. Levine;Faina Akselrod

  • Identification of prognostic factors in advanced epithelial ovarian carcinoma.

    Dennis S. Chi;John B. Liao;Larry F. Leon;Ennapadam S. Venkatraman

  • An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).

    Dennis S. Chi;Fernanda Musa;Fanny Dao;Oliver Zivanovic

  • Role of Imaging in Pretreatment Evaluation of Early Invasive Cervical Cancer: Results of the Intergroup Study American College of Radiology Imaging Network 6651–Gynecologic Oncology Group 183

    Hedvig Hricak;Constantine Gatsonis;Dennis S. Chi;Marco A. Amendola

  • The National Cancer Database report on advanced-stage epithelial ovarian cancer: Impact of hospital surgical case volume on overall survival and surgical treatment paradigm

    Robert E. Bristow;Bryan E. Palis;Dennis S. Chi;William A. Cliby

  • Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?

    Nadeem R. Abu-Rustum;Fady Khoury-Collado;Neeta Pandit-Taskar;Robert A. Soslow

  • Gynecologic cancer treatment and the impact of cancer-related infertility

    Jeanne Carter;Katherine Rowland;Dennis Chi;Carol Brown

  • The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian Carcinoma

    Dennis S. Chi;Ennapadam S. Venkatraman;Vivek Masson;William J. Hoskins

  • Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy

    Nadeem R Abu-Rustum;Mary L Gemignani;Kathleen Moore;Yukio Sonoda

  • Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.

    John P. Diaz;Yukio Sonoda;Mario M. Leitao;Oliver Zivanovic

Frequent Co-Authors

Nadeem R. Abu-Rustum
Nadeem R. Abu-Rustum Memorial Sloan Kettering Cancer Center
Yukio Sonoda
Yukio Sonoda Memorial Sloan Kettering Cancer Center
Richard R. Barakat
Richard R. Barakat Northwell Health
Douglas A. Levine
Douglas A. Levine New York University
Carol Aghajanian
Carol Aghajanian Memorial Sloan Kettering Cancer Center
Robert A. Soslow
Robert A. Soslow Memorial Sloan Kettering Cancer Center
Robert E. Bristow
Robert E. Bristow University of California, Irvine
Hedvig Hricak
Hedvig Hricak Memorial Sloan Kettering Cancer Center
William J. Hoskins
William J. Hoskins Memorial Sloan Kettering Cancer Center
Bernard H. Bochner
Bernard H. Bochner Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a career in medicine doesn't always begin in medical school. There are several affordable online degree options for those interested in healthcare that can serve as stepping stones or alternative career paths. For example, starting with medical billing and coding online courses cost considerably less than traditional programs and prepare students for administrative roles in the health sector.

If you prefer direct patient care, you might consider accredited nursing programs. There are many cheapest bsn programs online designed to help you earn a Bachelor of Science in Nursing from home while maintaining a flexible schedule.

For those looking to advance in clinical practice, exploring the cheapest fnp programs can open the door to becoming a Family Nurse Practitioner—a vital and high-demand role.

Ambitious professionals aiming for leadership, teaching, or advanced research roles in healthcare may be interested in online phd nursing programs. These advanced degrees make it possible to deepen your expertise and contribute to the medical field from anywhere.

Best Scientists Citing Dennis S. Chi

Trending Scientists

Recently Published Articles